STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Movano Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Movano (MOVE) reported an insider compensation change. On 11/03/2025, a director forfeited 13,271 RSUs previously awarded under the Omnibus Incentive Plan, in lieu of directors’ fees, and received a grant of stock options for 35,500 shares at an exercise price of $1.25.

The option award was contingent upon shareholder approval of an amendment to increase shares authorized under the plan; the options will become exercisable upon that approval. After the transaction, the director beneficially owned 1,874 shares of common stock directly.

Positive
  • None.
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cullinan Brian

(Last) (First) (Middle)
6800 KOLL CENTER PARKWAY

(Street)
PLEASANTON CA 94566

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Movano Inc. [ MOVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/03/2025 D 13,271(1) D $0 1,874 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy) $1.25 11/03/2025 A 35,500 (2) 12/31/2025 Common Stock 35,500 $0 35,500 D
Explanation of Responses:
1. The reported transaction involved the reporting person's forfeiture of previously awarded restricted stock units ("RSUs") under the Company's Omnibus Inctive Plan (the "Omnibus Incentive Plan") in lieu of directors' fees in exchange for the grant of stock options.
2. This option award was granted contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the number of shares of Common Stock authorized for issuance under the Plan (the "Plan Amendment"). The option will become exerciseable upon shareholder approval of the Plan Amendment.
/s/ Brian Cullinan by Mark R. Busch, attorney-in-fact 11/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Movano (MOVE) disclose in this Form 4?

A director forfeited 13,271 RSUs and was granted stock options for 35,500 shares at $1.25 on 11/03/2025.

Why were the RSUs forfeited by the Movano director?

They were forfeited in lieu of directors’ fees and exchanged for a stock option grant under the Omnibus Incentive Plan.

What conditions apply to the new stock options at Movano (MOVE)?

The options are contingent upon shareholder approval of a plan amendment; they become exercisable once approved.

What is the exercise price and size of the option grant?

The grant covers 35,500 shares at an exercise price of $1.25 per share.

How many Movano shares does the director own after the transaction?

Following the transaction, the director beneficially owned 1,874 shares directly.

When do the options expire if granted?

The options carry an expiration date of 12/31/2025, per the disclosure.
Movano Inc

NASDAQ:MOVE

MOVE Rankings

MOVE Latest News

MOVE Latest SEC Filings

MOVE Stock Data

8.47M
720.49k
24.94%
15.13%
13.54%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
PLEASANTON